HHS Harte Hanks Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * KEARNES LAURILEE	2. Issuer Name and Ticker or Trading Symbol HARTE HANKS INC [ HHS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Financial Officer
(Last)          (First)          (Middle) 9601 MCALLISTER FREEWAY, SUITE 610, SUITE 610	3. Date of Earliest Transaction (MM/DD/YYYY) 4/15/2019
(Street) SAN ANTONIO, TX 78216 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	4/15/2019		M		232	A	(1)	37706	D
Common Stock	4/15/2019		D		232	D	$3.59	37474	D
Common Stock	6/23/2019		M		520	A	(1)	37994	D
Common Stock	6/23/2019		D		520	D	$2.57	37474	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	4/15/2019		M			232	4/15/2019	4/15/2019	Common Stock	232	(1)	233	D
Phantom Stock	(1)	6/23/2019		M			520	6/23/2019	6/23/2019	Common Stock	520	(1)	1040	D

Explanation of Responses:
(1)	Each share of phantom stock was the economic equivalent of one share of the Issuer's common stock. All of the shares of phantom stock were cash settled.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
KEARNES LAURILEE 9601 MCALLISTER FREEWAY, SUITE 610 SUITE 610 SAN ANTONIO, TX 78216			Chief Financial Officer

Signatures
/s/ Attorney-in-Fact for Laurilee Kearnes		3/30/2020
**Signature of Reporting Person		Date